Ming Yan Ph.D.
Net Worth
Last updated:
What is Ming Yan Ph.D. net worth?
The estimated net worth of Dr. Ming Yan Ph.D. is at least $30,597,426 as of 18 Nov 2024. He owns shares worth $24,193,548 as insider, has earned $5,382,288 from insider trading and has received compensation worth at least $1,021,590 in Cytek Biosciences, Inc..
What is the salary of Ming Yan Ph.D.?
Dr. Ming Yan Ph.D. salary is $340,530 per year as Chief Technology Officer & Director in Cytek Biosciences, Inc..
How old is Ming Yan Ph.D.?
Dr. Ming Yan Ph.D. is 62 years old, born in 1963.
What stocks does Ming Yan Ph.D. currently own?
As insider, Dr. Ming Yan Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Cytek Biosciences, Inc. (CTKB) | Chief Technology Officer & Director | 5,988,502 | $4.04 | $24,193,548 |
What does Cytek Biosciences, Inc. do?
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Ming Yan Ph.D. insider trading
Cytek Biosciences, Inc.
Dr. Ming Yan Ph.D. has made 33 insider trades between 2022-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 62,456 units of CTKB stock on 7 Mar 2022. As of 18 Nov 2024 he still owns at least 5,988,502 units of CTKB stock.
Cytek Biosciences key executives
Cytek Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Ming Yan Ph.D. (62) Chief Technology Officer & Director
- Dr. Wenbin Jiang Ph.D. (61) Pres, Chief Executive Officer & Director
- Mr. Patrik Sebastian Jeanmonod (59) Chief Financial Officer